HeartCon Medical Celebrates Fifth Consecutive Year on Future Healthcare 100 List with Focus on Innovation and Smart Manufacturing

May 27, 2026 20:16 CST Updated 20:16

magAssist

Developer of Extracorporeal Artificial Heart Devices

Recently, the 10th 2026 Future Healthcare 100 series rankings hosted by VB100 were officially unveiled. Leveraging its accumulated R&D capabilities, stable clinical application outcomes of its products, and a comprehensive smart manufacturing layout, magAssist,Successfully Selected for the 2026 Future Healthcare 100 Innovative Medical Devices and Intelligent Manufacturing List. To date, magAssist has alreadyRanked on the Future Healthcare 100 List for five consecutive years. The company has long been deeply rooted in the innovative medical device sector, consistently adhering to independent technological innovation while simultaneously advancing the intelligent upgrading of production lines. Leveraging the dual synergy of R&D and smart manufacturing, it steadily drives the sustained development of the life support industry in China.。

2026 Future Healthcare Top 100

Innovative Medical Devices and Intelligent Manufacturing Ranking

Top 100 List

Currently, technological innovation and intelligent manufacturing have become the primary development directions for the medical device industry. Grounded in the current industry landscape and actual clinical needs, magAssist remains committed to pragmatic innovation. On one hand, it continuously tackles core and critical technologies to bridge technical gaps within the industry; on the other hand, it steadily advances the intelligent transformation of its production lines, implementing large-scale and standardized manufacturing of core medical equipment, while effectively balancing R&D innovation capabilities with practical mass production capacities.

Leveraging independent and controllable innovative technologies, the company has established three complete product pipelines encompassing extracorporeal fully magnetically levitated artificial hearts, ECMO systems, and interventional artificial hearts, complemented by smart manufacturing production lines tailored for their mass production. While continuously iterating its products and optimizing technical solutions, the company consistently refines the intelligent production workflows to enhance manufacturing efficiency and quality control standards. Through standardized and large-scale smart manufacturing, it ensures a stable supply and reliably controlled quality of emergency life-support devices, successfully translating its R&D and innovative achievements into clinical practice to serve patients.

Looking ahead, magAssist will remain true to its founding mission, focusing on core business development in the life support sector. With technological innovation as its core driving force and intelligent manufacturing as its production guarantee, the company will steadily optimize product performance, accelerate clinical translation, and meticulously ensure the quality of every life support device. This commitment will effectively support clinical emergency and critical care treatment. Through continuous innovation and intelligent manufacturing, magAssist will drive the steady and healthy development of the China-produced medical device industry.

-END-